We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$127M
AUM Growth
+$153K
(+0.12%)
Cap. Flow
+$1.75M
Cap. Flow
% of AUM
1.38%
Top 10 Holdings %
Top 10 Hldgs %
30.97%
Holding
147
New
23
Increased
40
Reduced
44
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$1.96M |
| 2 |
Novartis
NVS
|
+$1.31M |
| 3 |
Cisco
CSCO
|
+$743K |
| 4 |
AbbVie
ABBV
|
+$729K |
| 5 |
Johnson Controls International
JCI
|
+$611K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVA
Covanta Holding Corporation
CVA
|
+$1.98M |
| 2 |
AERI
Aerie Pharmaceuticals
AERI
|
+$1.67M |
| 3 |
Apple
AAPL
|
+$1.07M |
| 4 |
Terex
TEX
|
+$870K |
| 5 |
Citigroup
C
|
+$718K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.14% |
| 2 | Healthcare | 16.68% |
| 3 | Real Estate | 16.39% |
| 4 | Technology | 12.22% |
| 5 | Financials | 9.96% |
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q2 2017 Portfolio in Review
As of Q2 2017, Benchmark Capital Advisors held 147 positions worth $127M, up 0.12% from $127M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Benchmark Capital Advisors's Q2 2017 filing shows 23 new, 40 increased, 44 reduced and 7 closed positions. Its largest new stake was WisdomTree Japan Hedged Equity Fund: 38,230 shares worth $1.99M. The largest sale was Covanta Holding Corporation, an estimated $1.98M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Real Estate.
- Benchmark Capital Advisors's largest Q2 2017 buy was WisdomTree Japan Hedged Equity Fund: 38,230 shares worth $1.99M.
- Benchmark Capital Advisors added most to Devon Energy in Q2 2017, an estimated $530K increase.
- Benchmark Capital Advisors's biggest Q2 2017 reduction was Aerie Pharmaceuticals, cutting an estimated $1.67M.
- Benchmark Capital Advisors fully exited Covanta Holding Corporation in Q2 2017, selling an estimated $1.98M.
- Benchmark Capital Advisors's ten largest holdings make up 31% of its $127M portfolio in Q2 2017.
- Benchmark Capital Advisors opened 23 new positions and closed 7 in Q2 2017.
- Benchmark Capital Advisors's portfolio value rose 0.12% quarter-over-quarter to $127M.
Based on Benchmark Capital Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.